levodopa has been researched along with Bewilderment in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (51.72) | 18.7374 |
1990's | 4 (13.79) | 18.2507 |
2000's | 6 (20.69) | 29.6817 |
2010's | 2 (6.90) | 24.3611 |
2020's | 2 (6.90) | 2.80 |
Authors | Studies |
---|---|
Feldman, M; Margolesky, J; Marmol, S; Singer, C | 1 |
Brigo, F; Lorusso, L; Martini, M | 1 |
Baas, H; Gerlach, M; Kassubek, J; Müller, T; Reichmann, H; Riederer, P; Schrader, C; Urban, PP; Woitalla, D | 1 |
Ngamreungphong, S; Nugent, K; Singhatiraj, E | 1 |
Cavalcante, JE; Ferraz, FP; Santos, LF; Silva, DJ; Silva, LG; Sousa, JT; Souza, HA; Vilela Filho, O | 1 |
Kleiner-Fisman, G; Lang, AE; Lozano, A; Miyasaki, J; Saint-Cyr, JA | 1 |
Agid, Y; Bejjani, BP; Houeto, JL; Mallet, L; Mesnage, V; Welter, ML | 1 |
Ward, C | 1 |
Eberly, SW; Goetz, CG; Oakes, D; Schwid, SR; Shoulson, I | 1 |
Coignet, A; de Recondo, J; Rondot, P; Ziegler, M | 1 |
Goldstein, M; Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Nelson, J; Neophytides, A; Walker, R | 1 |
Agid, Y; de Smet, Y; Dubois, B; Lhermitte, F; Ruberg, M; Serdaru, M | 1 |
Winn, P | 1 |
Bliwise, DL; Hughes, M; Irbe, D; Rye, DB; Watts, N; Watts, RL | 1 |
Harper, J; Vieira, B | 1 |
Bonoma, RA; Iwuagwu, CU; Riley, D | 1 |
Del Pesce, M; Di Bella, P; Forastieri, L; Paggi, A; Quattrini, A | 1 |
Dumas, M; Dumond, JJ; Garoux, R; Leger, JM; Lombertie, E | 1 |
Klawans, HL; Moses, H; Moskovitz, C | 1 |
Chalmers, RJ; Johnson, RH; McLellan, DL | 1 |
Altus, P; Hencey, MA; Weissman, MS | 1 |
Golden, WE; Lavender, RC; Metzer, WS | 1 |
Douyon, R; Klutchko, B; Rotrosen, J; Serby, M | 1 |
Mondal, BK; Mondal, KN | 1 |
Duvoisin, RC; Sage, JI | 1 |
Lang, AE | 1 |
McDowell, FH; Sweet, RD | 1 |
Baker, AB; Loewenson, RB; Martin, WE; Resch, JA | 1 |
Cane, DB | 1 |
3 review(s) available for levodopa and Bewilderment
Article | Year |
---|---|
Amantadine Revisited: A Contender for Initial Treatment in Parkinson's Disease?
Topics: Amantadine; Animals; Antiparkinson Agents; Confusion; Delayed-Action Preparations; Dopamine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parkinson Disease | 2021 |
Laboratory assessments in the course of Parkinson's disease: a clinician's perspective.
Topics: Clinical Laboratory Techniques; Confusion; Dementia; Diagnosis, Differential; Humans; Levodopa; Parkinson Disease; Psychotic Disorders; Vitamins | 2016 |
[Psychiatric manifestations induced by dopamine precursors or antagonists].
Topics: Anxiety; Bromocriptine; Confusion; Dopamine Antagonists; Dreams; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride | 1979 |
4 trial(s) available for levodopa and Bewilderment
Article | Year |
---|---|
[Efficacy and side-effects of long term L-dopa therapy in Parkinsonian syndromes (evaluated by CT scan as well) (author's transl)].
Topics: Adult; Benserazide; Brain; Carbidopa; Clinical Trials as Topic; Confusion; Electrocardiography; Electroencephalography; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Stomach Diseases; Tomography, X-Ray Computed | 1979 |
Clinical and pharmacological evaluation of the effects of piribedil in patients with parkinsonism.
Topics: Aged; Antiparkinson Agents; Chorea; Clinical Trials as Topic; Confusion; Dioxoles; Dopamine; Drug Evaluation; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Motor Skills; Muscle Rigidity; Nausea; Parkinson Disease; Parkinson Disease, Postencephalitic; Piperazines; Pyrimidines; Tremor | 1975 |
A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
Topics: Affective Symptoms; Aged; Anxiety; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therapy, Combination; Female; Hallucinations; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Placebos; Sleep Wake Disorders; Time Factors; Trihexyphenidyl; Vomiting | 1974 |
Piribedil in Parkinsonism.
Topics: Antiparkinson Agents; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease | 1974 |
22 other study(ies) available for levodopa and Bewilderment
Article | Year |
---|---|
"You Are Older, although You Do Not Know That": Time, Consciousness, and Memory in "A Kind of Alaska" by Harold Pinter (1930-2008).
Topics: Adult; Alaska; Confusion; Consciousness; Female; Humans; Levodopa; Middle Aged; Parkinson Disease, Postencephalitic | 2021 |
Acute dopamine depletion syndrome.
Topics: Aged; Alzheimer Disease; Confusion; Creatine Kinase; Dopamine; Dopamine Agents; Female; Fever; Humans; Hypothyroidism; Levodopa; Muscle Rigidity; Parkinson Disease | 2010 |
Stereotactic subthalamic nucleus lesioning for the treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Combined Modality Therapy; Confusion; Dysarthria; Dyskinesias; Electric Stimulation; Electrocoagulation; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Prospective Studies; Recurrence; Safety; Severity of Illness Index; Stereotaxic Techniques; Subthalamic Nucleus; Tomography, X-Ray Computed; Treatment Outcome | 2001 |
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
Topics: Confusion; Depression; Dopamine Agonists; Dysarthria; Electric Stimulation Therapy; Follow-Up Studies; Humans; Levodopa; Motor Activity; Parkinson Disease; Substance Withdrawal Syndrome; Subthalamic Nucleus; Time; Treatment Outcome | 2003 |
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
Topics: Confusion; Depression; Dopamine Agonists; Electric Stimulation Therapy; Follow-Up Studies; Levodopa; Mood Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease; Quality of Life; Social Behavior Disorders; Substance Withdrawal Syndrome; Subthalamic Nucleus; Time; Treatment Outcome | 2003 |
Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Topics: Aged; Antiparkinson Agents; Confusion; Dantrolene; Deep Brain Stimulation; Dehydration; Dopamine Agents; Drug Monitoring; Electrolytes; Fever; Humans; Leukocyte Count; Levodopa; Magnetic Resonance Imaging; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Nurse's Role; Nursing Assessment; Parkinson Disease; Physical Examination; Substance Withdrawal Syndrome; Time Factors; Urinalysis | 2005 |
Safety of rasagiline in elderly patients with Parkinson disease.
Topics: Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Confusion; Disorders of Excessive Somnolence; Dopamine Agonists; Double-Blind Method; Female; Hallucinations; Humans; Hypotension, Orthostatic; Incidence; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Randomized Controlled Trials as Topic | 2006 |
Mental disorders in Parkinson's disease after treatment with L-DOPA.
Topics: Aged; Anxiety Disorders; Confusion; Delirium; Dementia; Depressive Disorder; Female; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1984 |
Further studies with pergolide in Parkinson disease.
Topics: Adult; Aged; Carbidopa; Confusion; Drug Combinations; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1982 |
Confusion, dementia and anticholinergics in Parkinson's disease.
Topics: Cognition Disorders; Confusion; Dementia; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1982 |
Adverse reactions to Sinemet CR.
Topics: Aged; Antiparkinson Agents; Carbidopa; Confusion; Delayed-Action Preparations; Drug Combinations; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levodopa | 1995 |
Disruptive nocturnal behavior in Parkinson's disease and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Behavior; Circadian Rhythm; Confusion; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Psychomotor Agitation; Sleep, REM | 1995 |
Catechol-O-methyltransferase inhibitors in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzophenones; Catechol O-Methyltransferase Inhibitors; Confusion; Drug Interactions; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Humans; Levodopa; Nitrophenols; Parkinson Disease; Tolcapone | 1998 |
Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a-catechol-o-methyl transferase inhibitor.
Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Confusion; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Nitrophenols; Substance Withdrawal Syndrome; Tolcapone | 2000 |
Levodopa-induced psychosis: a kindling phenomenon.
Topics: Adult; Aged; Chronic Disease; Confusion; Corpus Striatum; Delusions; Dreams; Female; Hallucinations; Humans; Levodopa; Limbic System; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Dopamine; Stimulation, Chemical; Time Factors | 1978 |
A 73-year-old woman with confusion, rigidity, and fever.
Topics: Aged; Carbidopa; Confusion; Drug Therapy, Combination; Female; Fever; Humans; Levodopa; Muscle Rigidity; Neuroleptic Malignant Syndrome; Parkinson Disease | 1991 |
Acute postoperative confusion and hallucinations in Parkinson disease.
Topics: Aged; Aged, 80 and over; Carbidopa; Cognition Disorders; Confusion; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Postoperative Complications; Retrospective Studies; Risk | 1989 |
ECT and Parkinson's disease revisited: a "naturalistic" study.
Topics: Aged; Carbidopa; Confusion; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1989 |
Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy.
Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Confusion; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Hydrazines; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease | 1986 |
Sudden onset of confusion with severe exacerbation of parkinsonism during levodopa therapy.
Topics: Aged; Carbidopa; Cognition Disorders; Confusion; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levodopa; Male; Parkinson Disease, Secondary | 1986 |
Sudden confusion with levodopa withdrawal.
Topics: Cognition Disorders; Confusion; Humans; Levodopa; Parkinson Disease; Parkinson Disease, Secondary; Substance Withdrawal Syndrome | 1987 |
The "on-off" response to chronic L-DOPA treatment of Parkinsonism.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Confusion; Dietary Proteins; Enzyme Inhibitors; Female; Gait; Humans; Levodopa; Male; Methyldopa; Movement Disorders; Muscle Cramp; Parkinson Disease; Time Factors | 1974 |